Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $2.7B bought by 683 insiders at 408 companies
- $17.1B sold by 1013 insiders outside a trading plan
- $13.6B sold by 1242 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past 3 months · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
RSGRepublic Services, Inc.Cascade Investment, L.l.c.10% owner · +1 joint filer$454M
-
JEFJefferies Financial Group Inc.Sumitomo Mitsui Financial Group, Inc.Director$324M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$179M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$158M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
COE51Talk Online Education GroupJack Jiajia HuangCEO$102M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$74.4M
-
FTKFlotek Industries, Inc.Matthew WilksDirector$34.3M
Biggest sales
Past 3 months · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
IHTInnSuites Hospitality TrustJames F WirthCEO$3.7B
-
BIRKBirkenstock Holding plcJames Michael ChuDirector$1.1B
-
NVDANvidia Corporation ComMark A StevensDirector$947M
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
JMKEJersey Mike's Subs Inc.Blackstone Holdings II L.P.10% owner · +4 joint filers$705M
-
AURAurora Innovation, Inc.Uber Technologies, Inc10% owner$654M
-
ALHAlliance Laundry Holdings Inc.Bdt Capital Partners, LLCDirector · +6 joint filers$590M
-
CRBGCorebridge Financial Inc.Argon Holdco LLC10% owner · +5 joint filers$491M
-
CRWVCoreWeave, Inc.Magnetar Financial LLC10% owner · +3 joint filers$479M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Che-Chia Wei CEO, Yung-Pei Chin COO, Kevin Xiaoqiang Zhang COO, Shien-Yang Wu SVP, +17 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more
-
Ryan Cohen CEO, Lawrence Cheng Director, Alain Attal Director, Nat Turner Director, +1 more
-
Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Lawrence B Seidman Director, Eric J Dale Director, Carl M Porto Director, Jeffrey R Dunne Director, +1 more
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Matthew Reade Miller DirectorGRNTGranite Ridge Resources, Inc.Buy$50K 10,000 shares at $5.03 +0.5% to stakeTraded Sep 11 Filed Sep 14
-
Steven P Novak DirectorOXSQOxford Square Capital Corp.Sale$6,775 5,000 shares at $1.36 25% of stakeTraded Sep 3 Filed Sep 14
-
Fernando Adrian Elsztain DirectorCRESYCresud S.A.C.I.F. y A.Sale$123K 100,000 shares at $1.23 16% of stakeTraded Sep 9–10 Filed Sep 14
-
James W Wert DirectorPKOHPark-Ohio Holdings Corp.Sale$92K 2,000 shares at $46.21 2.1% of stakeTraded Sep 11 Filed Sep 14
-
Lewis H Titterton Jr. DirectorANIXAnixa Biosciences, Inc.Buy$27K 10,000 shares at $2.73 +1% to stakeTraded Sep 10 Filed Sep 14
-
Yoav Chelouche DirectorTSEMTower Semiconductor Ltd.Sale$50K 232 shares at $215.06 0.7% of stakeTraded Sep 10 Filed Sep 14
-
Ramiro Guerrero DirectorMAIAMAIA Biotechnology, Inc.Buy$50K 37,595 shares at $1.32 +5.1% to stakeTraded Sep 10 Filed Sep 14
-
Silver Lake Partners V DE (AIV), L.P. Director · +4 joint filersDELLDell Technologies Inc.Sale$14.9M 27,629 shares at $540.39 53% of stakeTraded Sep 9 Filed Sep 11
-
Silver Lake Technology Investors IV, L.P. Director · +4 joint filersDELLDell Technologies Inc.Sale$581K 1,075 shares at $540.38 100% of stakeTraded Sep 9 Filed Sep 11
-
Silver Lake Technology Investors V, L.P. Director · +4 joint filersDELLDell Technologies Inc.Sale$263K 486 shares at $540.40 100% of stakeTraded Sep 9 Filed Sep 11
-
Silver Lake Partners IV, L.P. Director · +4 joint filersDELLDell Technologies Inc.Sale$29.5M 54,608 shares at $540.18Traded Sep 9 Filed Sep 11
-
Sl Spv-2, L.P. Director · +4 joint filersDELLDell Technologies Inc.Sale$26M 48,097 shares at $540.39 50% of stakeTraded Sep 9 Filed Sep 11
-
John W Raymond DirectorIONQIonQ, Inc.Planned sale$90K 2,407 shares at $37.21 3% of stakeTraded Sep 10 Filed Sep 11
-
Matthew Rabinowitz ChairNTRANatera, Inc.Planned sale$16.4M 50,000 shares at $327.97 2.2% of stakeTraded Sep 11 Filed Sep 11
-
Timothy Hayes DirectorHITHealth In Tech, Inc.Sale$16K 17,730 shares at $0.9200 13% of stakeTraded Sep 9–11 Filed Sep 11
-
Kenneth W Lowe DirectorWBDWarner Bros Discovery Inc.Sale$5.6M 200,000 shares at $28.23 25% of stakeTraded Sep 10 Filed Sep 11
-
Laurence Reid DirectorMGXMetagenomi Therapeutics, Inc.Buy$23K 20,000 shares at $1.17 New stakeTraded Sep 9 Filed Sep 11
-
Robin Shane Readnour DirectorANTXAN2 Therapeutics, Inc.Planned sale$6,675 1,108 shares at $6.02 0.2% of stakeTraded Sep 9 Filed Sep 11
-
Teresa Briggs DirectorDOCUDocuSign, Inc.Planned sale$35K 548 shares at $64.60 4.8% of stakeTraded Sep 10 Filed Sep 11
-
Peter Solvik DirectorDOCUDocuSign, Inc.Sale$3M 46,000 shares at $65.24 48% of stakeTraded Sep 10 Filed Sep 11
-
Robert E Landry DirectorCYTKCytokinetics, IncorporatedPlanned sale$75K 1,000 shares at $74.66 9.8% of stakeTraded Sep 11 Filed Sep 11
-
Elliott Robinson DirectorHNGEHinge Health, Inc.Sale— 0 sharesTraded Sep 9 Filed Sep 11
-
Sean P Downes ChairUVEUniversal Insurance Holdings Inc.Sale$880K 20,000 shares at $43.98 1.8% of stakeTraded Sep 11 Filed Sep 11
-
Timothy F Keaney DirectorUNMUnum GroupSale$404K 4,300 shares at $94.02 11% of stakeTraded Sep 10 Filed Sep 11
-
Michael Schmertzler DirectorPTCTPTC Therapeutics, Inc.Planned sale$1.4M 20,000 shares at $67.59 1.5% of stakeTraded Sep 9–10 Filed Sep 11
-
David M. Rubenstein DirectorCGThe Carlyle Group Inc.Sale$17.1M 400,000 shares at $42.74 1.5% of stakeTraded Sep 11 Filed Sep 11
-
George Ted Rogers III DirectorVIPVulcan Infrastructure and Power Inc.Buy$5M 2,923,976 shares at $1.71 +2532% to stakeTraded Sep 10 Filed Sep 11
-
Eric Singer Director · +3 joint filersUEICUniversal Electronics Inc.Sale$603K 130,000 shares at $4.64 11% of stakeTraded Sep 10–11 Filed Sep 11
-
Robin Josephs DirectorSAFESafehold Inc. NewSale$138K 9,500 shares at $14.56 9.6% of stakeTraded Sep 9 Filed Sep 11
-
Robert C Field DirectorFUSBFirst US Bancshares, Inc.Buy$15K 907 shares at $16.46 +6.8% to stakeTraded Sep 10–11 Filed Sep 11
-
Ashwin Venkatraman DirectorSMSM Energy CompanySale$140K 3,650 shares at $38.28 23% of stakeTraded Sep 10 Filed Sep 11
-
Rehan Verjee DirectorTYRATyra Biosciences, Inc.Buy$20K 972 shares at $20.58 New stakeTraded Sep 9 Filed Sep 11
-
Sapire Rose Nicole Dominique Reich DirectorTBBBBBB Foods Inc.Sale$389K 7,623 shares at $51.00 100% of stakeTraded Sep 9 Filed Sep 11
-
Mejia Antonio J Campo DirectorNESRNational Energy Services Reunited CorpSale$2.2M 63,324 shares at $35.45 8.3% of stakeTraded Sep 9 Filed Sep 11
-
Kenneth A Goldman DirectorWLTHWealthfront CorporationPlanned sale$100K 10,000 shares at $10.00 17% of stakeTraded Sep 10 Filed Sep 11
-
Daryl Bradley DirectorPLMRPalomar Holdings, Inc.Buy$135 1 share at $131.96 +<0.1% to stakeTraded Sep 2 Filed Sep 11
-
William Frank Cruger Jr. DirectorMKTXMarketAxess Holdings, Inc.Sale$1M 6,164 shares at $163.20 60% of stakeTraded Sep 10 Filed Sep 11
-
Antoine M Doumet DirectorUSLMUnited States Lime & Minerals, Inc.Sale$2.2M 20,000 shares at $110.00 18% of stakeTraded Sep 9 Filed Sep 11
-
Paul Caine DirectorMGNIMagnite, Inc.Planned sale$118K 5,000 shares at $23.53 3.3% of stakeTraded Sep 10 Filed Sep 11
-
Priscilla Hung DirectorVEEVVeeva Systems Inc.Sale$196K 750 shares at $261.04 19% of stakeTraded Sep 9 Filed Sep 11
-
Chris Carr DirectorVMRKVivmark ResidentialSale$74K 1,130 shares at $65.28 20% of stakeTraded Sep 9 Filed Sep 11
-
Daniel C Staton ChairARRARMOUR Residential REIT, Inc.Sale$564K 35,583 shares at $15.86 100% of stakeTraded Sep 10 Filed Sep 11
-
Gregory G Montana DirectorPNFPPinnacle Financial Partners, Inc.Buy$49K 500 shares at $98.61 +11% to stakeTraded Sep 10 Filed Sep 11
-
Michael C Franson DirectorNWPXNWPX Infrastructure, Inc.Sale$369K 3,500 shares at $105.30 18% of stakeTraded Sep 9 Filed Sep 11
-
Steven I Sarowitz DirectorANGXAngel Studios, Inc.Buy$2.5M 488,637 shares at $5.19 +65% to stakeTraded Sep 9–10 Filed Sep 11
-
Leonard M Tannenbaum DirectorAFCGAdvanced Flower Capital Inc.Buy$121K 35,000 shares at $3.46 +0.5% to stakeTraded Sep 10 Filed Sep 11
-
Leslie B Daniels DirectorATEXAnterix Inc.Sale$210K 2,500 shares at $83.83 5.4% of stakeTraded Sep 10 Filed Sep 11
-
Robert W Walker DirectorFGBIFirst Guaranty Bancshares, Inc.Buy$93K 8,500 shares at $10.91Traded Sep 10 Filed Sep 11
-
Jeffrey A Meckler DirectorTVTXTravere Therapeutics, Inc.Planned sale$1.3M 20,000 shares at $67.31 18% of stakeTraded Sep 10 Filed Sep 11
-
David R Brennan DirectorINSMInsmed IncorporatedSale$3.1M 25,000 shares at $124.00 39% of stakeTraded Sep 9 Filed Sep 11
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,793 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.